search
Back to results

Home Infusors for Analgesia After Foot Surgery

Primary Purpose

Hallux Valgus

Status
Unknown status
Phase
Phase 4
Locations
Denmark
Study Type
Interventional
Intervention
elastomeric pump with reservoir of 500 ml, infusion rate of 8 ml/h
elastomeric pump with reservoir of 275 ml, infusion rate of 5 ml/h
Sponsored by
Frederiksberg University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hallux Valgus focused on measuring Postoperative pain treatment

Eligibility Criteria

19 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • All ambulatory patients (ASA 1-3) scheduled for foot and ankle surgery in spinal or general anesthesia that are willing to participate in the study after informed consent will be taken into consideration.
  • Age span: 19 -80 years.
  • When fertile females are included, we will make sure that they receive anticonceptive treatment.

Exclusion Criteria:

  • Contraindications for sciatic catheter placement and allergy to local anesthetics.
  • The patients with chronic pain receiving opioids, pregnant patients, those with rheumatoid arthritis, lever or heart disease.

Sites / Locations

  • Frederiksberg Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

A

B

Arm Description

Group A patients will receive perisciatic continuous infusion of ropivacaine 2 mg/ml through an elastomeric pump (Baxter, Deerfield, IL, USA)) 8 ml/h (reservoir of 500 ml)as postoperative analgesia.

Group B patients will receive standard treatment: continuous perisciatic infusion of 2 mg/ml ropivacaine 5 ml/t (Baxter infusor with 275 ml reservoir)

Outcomes

Primary Outcome Measures

worst pain

Secondary Outcome Measures

Average pain
Opioid consumption
Side effects

Full Information

First Posted
January 14, 2008
Last Updated
January 28, 2009
Sponsor
Frederiksberg University Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT00600899
Brief Title
Home Infusors for Analgesia After Foot Surgery
Official Title
Use of Home Pumps for Analgesia After Ambulatory Foot Surgery - Comparison of Two Infusion Rates - a Randomized, Double-Blind Study
Study Type
Interventional

2. Study Status

Record Verification Date
January 2009
Overall Recruitment Status
Unknown status
Study Start Date
September 2008 (undefined)
Primary Completion Date
December 2009 (Anticipated)
Study Completion Date
December 2010 (Anticipated)

3. Sponsor/Collaborators

Name of the Sponsor
Frederiksberg University Hospital

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this double blind, randomized study is to evaluate which rate and duration of infusion can be recommended for continuous perisciatic infusion of ropivacaine 2 mg/ml for analgesia after ambulatory foot surgery.
Detailed Description
Protocol title: Use of home pumps for analgesia after ambulatory foot surgery - comparison of two infusion rates SUMMARY in English THE PURPOSE: The purpose of this double blind, randomized study is to evaluate which rate and duration of infusion can be recommended for continuous perisciatic infusion of ropivacaine 2 mg/ml for analgesia after ambulatory foot surgery. BACKGROUND: In the previous study (1) we showed that the continuous perisciatic infusion of 2 mg/ml ropivacaine 5 ml/h for 55 hours provided better analgesia than placebo after ambulatory foot surgery. Similar results are reported by Singelyn (2), Ilfeld (3) and White (4). But, different pumps with different basal infusion rates were used in these studies. Singelyn used infusion rate of 7 ml/h for 48 hours, while Ilfeld used mechanical pump with adjustable infusion rate, starting with 8 ml/h and patient controlled analgesia (PCA) 2 ml/20 minutes for 2 postoperative days. In our and White's studies elastomeric pumps with reservoir of 500 ml and infusion rate of 5 ml/h were used in 55 hours. Capdevila (5) has shown that the patients prefer elastomeric pumps because they cause fewer problems. That is why it will be our choice as well. The analgesic efficacy in our study was good as the patients in the treatment group had less pain and fewer sleep disturbances than in the placebo group. The question is whether higher infusion rate and longer duration would have an even better effect. The aim of this study is to compare (in a double blind manner) two different regimens for continuous perisciatic nerve infusion of ropivacaine 2 mg/ml after ambulatory foot surgery: elastomeric pump with reservoir of 275 ml, infusion rate of 5 ml/h (duration 55 hours) and elastomeric pump with reservoir of 500 ml, infusion rate of 8 ml/h (duration 62 hours). Design: A randomized, double blind study with 40 ambulatory patients who will undergo foot or ankle surgery. These patients will be randomized to receive either regimen 1. (5 ml/h for 55 hours) or regimen 2. (8 ml/h for 62 hours). The randomization procedure: sequentially numbered, sealed, opaque envelopes that contain computer produced random numbers for treatment allocation. Blinding procedures: pre-numbered identical containers marked with "Test drug", date of production and infusion start/end will be provided by the registered nurse (SK). The patient and the acute pain nurse (EB), who will evaluate the effect of these two treatments, will be blinded. On each of the 3 postoperative days the patients will be contacted by phone by the acute pain nurse and a standard questionnaire will be completed. The primary effect variable is worst pain on the first postoperative day evaluated as VAS score.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hallux Valgus
Keywords
Postoperative pain treatment

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
40 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
A
Arm Type
Experimental
Arm Description
Group A patients will receive perisciatic continuous infusion of ropivacaine 2 mg/ml through an elastomeric pump (Baxter, Deerfield, IL, USA)) 8 ml/h (reservoir of 500 ml)as postoperative analgesia.
Arm Title
B
Arm Type
Active Comparator
Arm Description
Group B patients will receive standard treatment: continuous perisciatic infusion of 2 mg/ml ropivacaine 5 ml/t (Baxter infusor with 275 ml reservoir)
Intervention Type
Procedure
Intervention Name(s)
elastomeric pump with reservoir of 500 ml, infusion rate of 8 ml/h
Intervention Description
Continuous perisciatic infusion of ropivacaine 2mg/ml (Baxter infusor with 500 ml reservoir and infusion rate of 8 ml/h)
Intervention Type
Procedure
Intervention Name(s)
elastomeric pump with reservoir of 275 ml, infusion rate of 5 ml/h
Intervention Description
Continuous perisciatic infusion of ropivacaine 2mg/ml (Baxter infusor with 275 ml reservoir and infusion rate of 5ml/h)
Primary Outcome Measure Information:
Title
worst pain
Time Frame
first postoperative day
Secondary Outcome Measure Information:
Title
Average pain
Time Frame
1st, 2nd and 3rd postoperative days
Title
Opioid consumption
Time Frame
first, second and third postoperative days
Title
Side effects
Time Frame
1st, 2nd and 3rd postoperative days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
19 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: All ambulatory patients (ASA 1-3) scheduled for foot and ankle surgery in spinal or general anesthesia that are willing to participate in the study after informed consent will be taken into consideration. Age span: 19 -80 years. When fertile females are included, we will make sure that they receive anticonceptive treatment. Exclusion Criteria: Contraindications for sciatic catheter placement and allergy to local anesthetics. The patients with chronic pain receiving opioids, pregnant patients, those with rheumatoid arthritis, lever or heart disease.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Dusanka Zaric, MD pHd
Organizational Affiliation
Ndr. Fasanvej 57 2000 Frederiksberg
Official's Role
Principal Investigator
Facility Information:
Facility Name
Frederiksberg Hospital
City
Frederiksberg
ZIP/Postal Code
2000
Country
Denmark

12. IPD Sharing Statement

Citations:
PubMed Identifier
14982567
Citation
Zaric D, Boysen K, Christiansen J, Haastrup U, Kofoed H, Rawal N. Continuous popliteal sciatic nerve block for outpatient foot surgery--a randomized, controlled trial. Acta Anaesthesiol Scand. 2004 Mar;48(3):337-41. doi: 10.1111/j.0001-5172.2004.0327.x.
Results Reference
background

Learn more about this trial

Home Infusors for Analgesia After Foot Surgery

We'll reach out to this number within 24 hrs